Osaic Holdings’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $81.6K | Sell |
520
-263
| -34% | -$41.3K | ﹤0.01% | 4314 |
|
2025
Q1 | $123K | Buy |
783
+245
| +46% | +$38.6K | ﹤0.01% | 4016 |
|
2024
Q4 | $84.4K | Sell |
538
-53
| -9% | -$8.32K | ﹤0.01% | 4297 |
|
2024
Q3 | $105K | Sell |
591
-277
| -32% | -$49.1K | ﹤0.01% | 4179 |
|
2024
Q2 | $146K | Sell |
868
-1,134
| -57% | -$191K | ﹤0.01% | 3820 |
|
2024
Q1 | $333K | Sell |
2,002
-245
| -11% | -$40.8K | ﹤0.01% | 3263 |
|
2023
Q4 | $372K | Sell |
2,247
-212
| -9% | -$35.1K | ﹤0.01% | 3405 |
|
2023
Q3 | $383K | Buy |
2,459
+248
| +11% | +$38.6K | ﹤0.01% | 3483 |
|
2023
Q2 | $345K | Sell |
2,211
-138
| -6% | -$21.5K | ﹤0.01% | 3471 |
|
2023
Q1 | $381K | Buy |
2,349
+58
| +3% | +$9.4K | ﹤0.01% | 3328 |
|
2022
Q4 | $366K | Buy |
2,291
+146
| +7% | +$23.3K | ﹤0.01% | 3314 |
|
2022
Q3 | $302K | Buy |
2,145
+5
| +0.2% | +$704 | ﹤0.01% | 3376 |
|
2022
Q2 | $312K | Sell |
2,140
-1,414
| -40% | -$206K | ﹤0.01% | 3389 |
|
2022
Q1 | $549K | Sell |
3,554
-193
| -5% | -$29.8K | ﹤0.01% | 3143 |
|
2021
Q4 | $708K | Buy |
3,747
+1,398
| +60% | +$264K | ﹤0.01% | 2718 |
|
2021
Q3 | $476K | Sell |
2,349
-178
| -7% | -$36.1K | ﹤0.01% | 3082 |
|
2021
Q2 | $510K | Sell |
2,527
-805
| -24% | -$162K | ﹤0.01% | 3019 |
|
2021
Q1 | $585K | Buy |
3,332
+1,102
| +49% | +$193K | ﹤0.01% | 2713 |
|
2020
Q4 | $378K | Sell |
2,230
-107
| -5% | -$18.1K | ﹤0.01% | 2901 |
|
2020
Q3 | $379K | Sell |
2,337
-55
| -2% | -$8.92K | ﹤0.01% | 2688 |
|
2020
Q2 | $389K | Buy |
2,392
+324
| +16% | +$52.7K | ﹤0.01% | 2549 |
|
2020
Q1 | $198K | Buy |
+2,068
| New | +$198K | ﹤0.01% | 2864 |
|